Navigation Links
Biotech Company Ansaris Selects Surety for Integrity and Authenticity Protection of Its Lab Informatics Data
Date:1/28/2010

AbsoluteProof eases process scientists follow to "sign" and "witness" volumes of research records.

Reston, VA (PRWEB) January 28, 2010 -- Surety, LLC, the leading provider of data integrity protection solutions, today announced that Ansaris, a drug discovery and development company, has selected Surety's AbsoluteProof® trusted, digital timestamping service for integration into its lab informatics systems to protect the data's integrity and authenticity. With AbsoluteProof, information stored within Ansaris' electronic lab environment will be properly "sealed," ensuring its research records are in legally acceptable evidentiary form should the company's intellectual property rights and ownership to a particular invention ever be questioned or challenged.

Ansaris is a drug-discovery company focused on solving small-molecule challenges by utilizing its proprietary technology platform. The company integrates fragment-based drug design, protein modelling and medicinal chemistry and biology expertise to identify novel therapeutics. Critical to the drug-discovery process is the ability to prove "time of invention" in order to protect intellectual property that is generated.

"Prior to implementing AbsoluteProof, we required scientists to save their experiments to DVD, and then have them physically signed, countersigned and witnessed," said Joan Lau, President and CEO, Ansaris. "This process was labor-intensive and time consuming. Considering that only 20 percent of our industry has a purely electronic solution for archival, our challenge was to design and implement a lab informatics solution that could satisfy the requirements of proving inventorship."

Using its electronic lab notebooks (ELNs) as a starting point for its implementation of an electronic archival process, Ansaris scientists seamlessly export their experiments to the company's network, upon which AbsoluteProof then time stamps, or 'seals,' the document, recording the exact time, date and format in which it existed. The document is then conveniently accessible to additional scientists, who can then view the sealed electronic record. This process assures Ansaris and its scientists that their work is authentic and safe from potential tampering or intellectual property theft. What once took 15 scientists nearly 10 hours per month executing the process, Ansaris' electronic lab environment with AbsoluteProof integrated into it has since reduced the time to less than one hour per month. This translates into savings of hundreds of thousands of dollars per year.

"With AbsoluteProof, Ansaris and its collaboration partners can be confident in the fact that their scientific intellectual property data can and will remain secure with minimal time commitment from its scientists," said Bob Flinton, VP of Marketing and Product Management for Surety. "Being integrated into the Ansaris' ELN solution to improve the invention process, Surety's AbsoluteProof has helped the company reduce the amount of time and resources spent on managing electronic scientific records."

Legally Defensible Proof of Authenticity
As a Surety customer, Ansaris qualifies for Surety's Legal Defensibility Guarantee, delivering to Ansaris the confidence that its critical electronic records, files and other digital content will withstand the most vigorous legal scrutiny. Under the guarantee, Ansaris will receive access, if needed, to sworn affidavits and expert witness testimony to the quality of the underlying technology, confirming that the Seals provided by the AbsoluteProof service are authentic and have not been compromised, as well as a money-back guarantee should a federal, state or local court in any jurisdiction render a final and non-appealable decision that Surety has not been able to satisfy its claims.

For complete details about Ansaris' successful implementation of AbsoluteProof, visit www.surety.com/resources/success-stories. For more information about Surety or AbsoluteProof, visit www.surety.com.

About Surety, LLC
Founded in 1994 by leading Bellcore Scientists, Surety is recognized as a premiere third-party trusted time-stamp authority. With millions of electronic records and files worldwide protected under its authenticity seal, the company's flagship service offering AbsoluteProof® enables organizations to meet the legal, fiduciary and regulatory responsibilities associated with creating, managing and archiving electronic data by providing legally defensible evidence of integrity and authenticity. AbsoluteProof ensures against content or record tampering by providing a "digital wax seal" for all types of electronically stored content. The company's client base is made up of pharmaceutical and bio-technology companies, legal and financial services firms, research and development laboratories, healthcare organizations, managed services providers and copyright protection agencies that are ensuring record integrity with AbsoluteProof. For more information, visit www.surety.com.

About Ansaris
Ansaris is a division of Locus Pharmaceuticals, Inc., a privately held drug discovery and development company based in Blue Bell, PA, creating novel therapeutics using its patented drug-design technology. Ansaris has entered into several drug discovery collaboration projects with pharmaceutical partners, and has built a pipeline of early drug-development assets for cancer and inflammatory indications using its computational and medicinal chemistry resources and technology.

###

Read the full story at http://www.prweb.com/releases/2010/01/prweb3534524.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Glycos Biotechnologies Appoints Chief Executive Officer
2. Resverlogix Presenting at Biotech Showcase
3. Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
4. The Massachusetts Biotechnology Council Selects Social Media Marketing Agency 451 Marketing To Develop A Social Media Strategy For 2010
5. For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
6. For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
7. CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress
8. Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement
9. Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
10. Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Companys First Annual 2010 Micro Cap Conference
11. YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... LONDON , May 3, 2016 ... Report Assessing Developers and Producers of Those Competitor Biologics  ... Guide to Companies, Activities and Prospects ,  ... drug companies? And what are their sales potentials? ... There you see results, trends, opportunities and revenue forecasting. ...
(Date:5/2/2016)... -- Q BioMed Inc. (QBIO), a biotechnology ... Inc. will be attending the Association for Research in ... 1-5, 2016 in Seattle Washington . ... and research partners. The meeting provides organizations the opportunity ... opportunities for the MAN-01 program for treatment of glaucoma. ...
(Date:4/29/2016)... ... 2016 , ... The MIT bioLogic design team has won multiple A' ... properties can be applied to fabric and formed into living interfaces between body and ... humidity change. The team harvested Natto cells and applied them to fabric with custom ...
(Date:4/29/2016)... ... April 29, 2016 , ... During a ... technology into a viable company, CereScan’s CEO, John Kelley, joined other Denver business ... leader and mentor in the Denver area business community, shared his top fundamental ...
Breaking Biology Technology:
(Date:3/11/2016)... 2016 --> ... "Image Recognition Market by Technology (Pattern Recognition), by Component ... Deployment Type (On-Premises and Cloud), by Industry Vertical and ... MarketsandMarkets, the global market is expected to grow from ... by 2020, at a CAGR of 19.1%. ...
(Date:3/9/2016)... Fla. , March 9, 2016  Crossmatch ... authentication and enrollment solutions, today announced the addition ... ® Altus multi-factor authentication platform. New ... InfoSec managers to step-up security where it,s needed ... Washington, DC . --> ...
(Date:3/2/2016)... , March 2, 2016 ... the addition of the  "Global Biometrics Market ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global ... grow at a CAGR of around 27% ... ) has announced the addition of the  ...
Breaking Biology News(10 mins):